SN

Sakshi Nitin Shitole

Active Director Designated Partner DIN 08731316
DIN 08731316 First appointment Mar 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Sakshi Nitin Shitole

Data last updated:

Sakshi Nitin Shitole is a Designated Partner at Matrixx Remedies Llp (since 2020). The company operates in Pharma.

DIN 08731316
Primary Designation Designated Partner
Industry Pharma
First Appointment 31 Mar 2020
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner31 Mar 20202015Active

Board colleagues of Sakshi Nitin Shitole

NameDINCompanyDesignation
Sandipan Apparao Shitole06430852Matrixx Remedies LlpDesignated Partner
Supriya Nitin Shitole07182023Matrixx Remedies LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Matrixx Remedies Llp
Premium access

Shareholding and investment profile for Sakshi Nitin Shitole

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sakshi Nitin Shitole

Sakshi Nitin Shitole currently holds 1 directorship: Matrixx Remedies Llp (Designated Partner, since 31 Mar 2020).

Sakshi Nitin Shitole was first appointed on 31 Mar 2020 as Designated Partner at Matrixx Remedies Llp.

The current boards of Sakshi Nitin Shitole's companies include Sandipan Apparao Shitole (Matrixx Remedies Llp), Supriya Nitin Shitole (Matrixx Remedies Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available